Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 10—October 2010
Research

Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA

Scott K. HeysellComments to Author , Jane L. Moore, Suzanne J. Keller, and Eric R. Houpt
Author affiliations: Author affiliations: University of Virginia, Charlottesville, Virginia, USA (S.K. Heysell, E.R. Houpt); Virginia Department of Health, Richmond, Virginia, USA (J.L. Moore, S.J. Keller)

Main Article

Table 3

Risk factors for INH or RIF serum concentration levels below the expected range 2 hours after medication administration among persons with slow responses, therapeutic drug monitoring, Virginia, USA, March 1, 2007–May 1, 2009*

Characteristic Normal INH,
n = 16,
no. (%) Low INH, n = 23,
no. (%) Bivariate risk ratio (95% CI); p value Normal RIF,
n = 20,
no. (%) Low RIF,
n = 22,
no. (%) Bivariate risk ratio (95% CI); p value
Age, y
18–39 4 (25) 8 (35) Referent 5 (25) 10 (46) Referent
40–64 7 (44) 8 (35) 0.57 (0.12–2.80); p = 0.49 8 (40) 7 (32) 0.44 (0.10–1.90); p = 0.27
>65
5 (31)
7 (30)
0.70 (0.13–3.70); p = 0.67
7 (35)
5 (22)
0.36 (0.07–1.70); p = 0.20
Sex
M 11 (69) 15 (65) Referent 13 (65) 15 (68) Referent
F
5 (31)
8 (35)
1.2 (0.30–4.60); p = 0.82
7 (35)
7 (32)
0.87 (0.24–3.10); p = 0.81
Race/Ethnicity
White 1 (6) 3 (13) 1.9 (0.16–22.30); p = 0.61 3 (15) 1(5) 0.37 (0.3–4.2); p = 0.42
Asian 7 (44) 11 (48) Referent 10 (50) 9 (41) Referent
Hispanic/Latino 6 (38) 4 (17) 0.42 (0.09–2.10); p = 0.43 3 (15) 8 (36) 3.0 (0.60–14.70); p = 0.18
Black
2 (12)
5 (22)
1.6 (0.24–10.60); p = 0.63
4(20)
4 (18)
1.1 (0.21–5.80); p = 0.90
Foreign-born
No 3 (19) 6 (26) Referent 6 (30) 3 (14) Referent
Yes
13 (81)
17 (74)
0.65 (0.14–3.10); p = 0.59
14 (70)
19 (86)
2.7 (0.58–12.80); p = 0.21
Diabetes
No 10 (63) 13 (57) Referent 16 (80) 9 (41) Referent
Yes
6 (37)
10 (43)
1.3 (0.35–4.70); p = 0.71
4 (20)
13 (59)
5.8 (1.4–23.1); p = 0.01†
Alcohol abuse
No 15 (94) 22 (96) Referent 18 (90) 20 (91) Referent
Yes
1 (6)
1 (4)
0.69 (0.40–11.70); p = 0.79
2 (10)
2 (9)
0.90 (0.12–7.10); p = 0.92
Dose interval
Daily 8 (50) 19 (83) Referent 11 (65) 16 (73) Referent
Biweekly 8 (50) 4 (17) 0.21 (0.05–0.90); p = 0.04‡ 6 (35) 6 (27) 0.88 (0.23–3.30); p = 0.85

*INH, isoniazid; RIF, rifampin; CI, confidence interval. Low is defined as below expected range; normal is defined as within or above expected range.
†Adjusted odds ratio 5.7 (1.2–25.7); p = 0.03.
‡Adjusted odds ratio 0.47 (0.09–2.50); p = 0.37.

Main Article

Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external